Bizarre Patents
Self Containing Enclosure for Protection from Killer Bees
A self contained protective enclosure with an opening for entry and egress and a screen for ventilation and viewing.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8143449 | Process for the synthesis of agomelatine Process for the industrial synthesis of the compound of formula (I) ... | 03/27/2012 |
| 8067639 | Crystalline form VI of agomelatine, a process for its preparation and pharmaceutical compositions containing it Crystalline form VI of the compound of formula (I): characterised by its X-ray powder diffraction diagram. Medicinal products containing the same which are useful in treating melatoninergic disorders. ... | 11/29/2011 |
| 7947852 | Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them Compounds of formula (I): wherein: R1 represents alkyl, alkenyl, haloalkyl, polyhaloalkyl, cycloalkyl, cycloalkylalkyl, aryl, arylalkyl, heteroaryl or heteroarylalkyl, X represents a gro... | 05/24/2011 |
| 7608737 | Naphthyl(ethyl)acetamides This disclosure relates to novel melatonin analogues or naphthyl(ethyl)acetamides, their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This disclosure also provides compositions comprising a compound of this disclosure and the use o... | 10/27/2009 |
| 7601870 | Substituted aniline derivatives The present invention relates to aniline derivatives of the general formula I or salts thereof, described therein, and their use. ... | 10/13/2009 |
| 7470814 | Process for the preparation of substituted 7-allyl-6-hydroxy-indanes The present invention relates to a novel process for the industrial manufacture of substituted 7-allyl-6-hydroxy-indanes of formula (I) wherein R is a straight or branched (C1-C6)alkyl group and X is a... | 12/30/2008 |
| 7462741 | Naphthalene compounds A compound selected from those of formula (I): Medicinal products containing the same which are useful in the treatment of disorders of the melatoninergic system. ... | 12/09/2008 |
| 7423179 | Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine Treatment of CNS disorders with (1R,4S)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine; and (1S,4R)-trans 4-(3,4-dichlorophenyl)- 1,2,3,4-tetrahydro-1-napthalenamine is disclosed. A process for preparing 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-... | 09/09/2008 |
| 7312345 | Process for the preparation of dronedarone The present invention provides, according to an aspect thereof, a novel process for the preparation of dronedarone [1] and pharmaceutically acceptable salts thereof. According to a preferred embodiment, the process comprises N-acetylating of p-anisidine or p-pheneti... | 12/25/2007 |
| 7262326 | Process for the synthesis of indanylamine or aminotetralin derivatives and novel intermediates A process for preparing indanylamine and aminotetralin derivatives from indanone or tetralone oximes by acylating the oximes with an organic anhydride, followed by catalytic hydrogenation in the presence of an organic anhydride with subsequent hydrolysis is describe... | 08/28/2007 |
| 7154004 | Catalytic transamidation and amide metathesis under moderate conditions Disclosed is a method of manipulating the carboxamide functionality in a catalytic manner. The method includes the steps of reacting amides with or without amines in the presence of various types of metal catalysts, at a temperature of about 250° C. or less. ... | 12/26/2006 |
| 7141674 | Anti-inflammatory compounds This invention relates to anti-inflammatory compounds, methods of making such compounds and methods of using such compounds having the following structure: ... | 11/28/2006 |
| 7138547 | Antitumoral compounds New spisulosine derivatives of use in treating tumors are of the formula (I) wherein: each X is the same or different, and represents H, OH, OR′, SH, SR′, SOR′, SO2R′, NO2, NH2, NHR′, N(R′)2, CN, halogen, C(═... | 11/21/2006 |
| 7105699 | Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide Treatment of CNS disorders with (1R,4S)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine; and (1S,4R)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine is disclosed. A process for preparing 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-n... | 09/12/2006 |
| 7087785 | Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine and its formamide Treatment of CNS disorders with (1R,4S)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine; and (1S,4R)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine is disclosed. A process for preparing 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-n... | 08/08/2006 |
| 6930190 | Process for the preparation of heterocyclic pentalene derivatives A process for preparing heterocyclic pentalene derivative having formula (I): wherein w is a sulfur atom (S), an oxygen atom (O) or a NR or PR group, wherein R is an hydrocarbon group; R1, R2, R3, and R4, equal to or diffe... | 08/16/2005 |
| 6888015 | Sphingolipid synthesis inhibitor A inhibitor of sphingolipids synthesis comprising a compound represented by general formula A. Desirably, a novel inhibitor of sphingolipids synthesis comprising (1R, 3R) N-(3-hydroxy-1-hydroxymethyl-3-phenylpropyl) alkaneamide, wherein carbon number of alkanoyl gro... | 05/03/2005 |
| 6870069 | Phenyloxyaniline derivatives A phenyloxyaniline derivative useful as a ligand for peripheral benzodiazepine receptor having a strong affinity and a high selectivity, which is represented by formula (1): wherein X1 and X2 are ... | 03/22/2005 |
| 6855847 | Process for producing optically active amide from α β- unsaturated amide derivative in the presence of transition metal complex containing phosphine-phosphorane compound and transition metal A novel process for producing an optically active amide excellent in chemical selectivity and enantioselectivity by asymmetric hydrogenation of an α,β-unsaturated amide and also allowing the reaction to proceed efficiently even when a trace amount of a catalyst is... | 02/15/2005 |
| 6720453 | Formoterol tartrate polymorph A method of preparation of a highly pure salt of R,R-formoterol L-tartrate is disclosed. The process provides the most thermodynamically stable polymorph by recrystallization of a novel polymorph. ... | 04/13/2004 |
| 6635650 | Substituted dimeric compounds The invention relates to compounds of formula (I): wherein: A represents NR1 C(Q)R2, C(Q)NR2 R3 or NR1 C(Q)NR2 R3, B represents NR1 C(Q)R2, C(Q)NR2... | 10/21/2003 |
| 6617351 | Amide, carbamate, and urea derivatives The present invention provides certain amide, carbamate and urea derivatives useful for potentiating glutamate receptor function in a mammal and therefore, useful for treating a wide variety of conditions, such as psychiatric and neurological disorders.... | 09/09/2003 |
| 6602903 | Substituted heterocyclic compounds The invention relates to compounds of formula (I): ##STR1## and medicinal products containing the same are useful in treating or in preventing melatoninergic disorders.... | 08/05/2003 |
| 6583319 | Cyclic compounds having a cycloalkylene chain The invention relates to compounds of for a (I): ##STR1## wherein: R represents ORa, SRa or Ra or a cyclic group A is a cyclic structure G1 and G2 represent an alkylene chain or a single bond B represents --NR | 06/24/2003 |
| 6509369 | Anti-inflammatory compounds This invention relates to anti-inflammatory compounds, methods of making such compounds and methods of using such compounds having the following structure: ##STR1##... | 01/21/2003 |
| 6498276 | Process for producing acetophenone compound The present invention relates to a method for producing a compound of the formula [71] ##STR1## wherein R1 is an optionally substituted cycloalkyl group, an optionally substituted aryl group or an optionally substituted heterocyclic group,... | 12/24/2002 |
| 6482985 | 2-benzyloxy-5-halo-acylanilide compounds and method of using them Disclosed is a compound comprising a 2-benzyloxy-5-haloacylanilide having the structural formula I: ##STR1## wherein R is hydrogen or an alkyl group, RA is a substituent and n is 0-5; and X is a halogen. Also disclosed is a method for preparing a co... | 11/19/2002 |
| 6423870 | Tricyclic compounds, preparation method and pharmaceutical compositions containing same The invention concerns compounds of formula (I) in which: A forms a tricyclic system of formula A1, A2, A3 or A4 ; R1 represents a hydrogen atom, an alkyl, hydroxy, alkoxy or oxo group; (R2... | 07/23/2002 |
| 6410749 | Process for the preparation of optically active amino alcohols Process for preparing optically active ଲ-amino alcohols represented by a general formula (2): Ra--C*H(OH)--C*H(Rb)--Rc wherein Ra and Rc are each independently hydrogen, optionally substituted alkyl, optionally substituted cycloalkyl, Rb is one memb... | 06/25/2002 |
| 6372779 | Anti-inflammatory compounds This invention relates to anti-inflammatory compounds, methods of making such compounds and methods of using such compounds having the following structure: ##STR1##... | 04/16/2002 |
| 6350902 | Process for the selective N-formylation of N-hydroxylamines The instant invention provides a process for the selective N-formylation of N-hydroxylamines.... | 02/26/2002 |
| 6297196 | Benzoyl derivatives, process for their preparation and their use as herbicides and plant growth regulators Benzoyl derivatives of the formula (I), process for their preparation and their use as herbicides and plant growth regulators are described. ##STR1## In this formula (I), R1, R2, R3, R4 and R5 are var... | 10/02/2001 |
| 6294573 | Reverse hydroxamate inhibitors of matrix metalloproteinases Compounds having the formula ##STR1## are matrix metalloproteinase inhibitors. Also disclosed are matrix metalloproteinase-inhibiting compositions and methods of inhibiting matrix metalloproteinase in a mammal.... | 09/25/2001 |
| 6235789 | Benzocycloalkene compounds, their production and use A compound of the formula ##STR1## wherein R1 and R2 are H, a hydrocarbon group or a heterocyclic group, or R1 and R2 are combinedly a spiro ring; R3 is a hydrocarbon group, a substituted amino group,... | 05/22/2001 |
| 6232498 | Process for the preparation of benzothiazolone compounds There are described processes for the preparation of a compound of formula I ##STR1## and novel intermediates in the preparative process.... | 05/15/2001 |
| 6187821 | Benzene compound and pharmaceutical use thereof A benzene compound of the formula: ##STR1## wherein each symbol is as defined in the specification; an optically active isomer or salt thereof, a medicinal composition containing the same, and an immunosuppressant containing the same as the active ingredi... | 02/13/2001 |
| 6169200 | Method for producing -hydroxy-ଲ-aminocarboxylic acids The present invention provides a simple and inexpensive method for producing -hydroxy-ଲ-aminocarboxylic acids and their esters. An ester of an N-protected -amino acid ester is converted into a ଲ-ketosulfoxide, which is then processed ... | 01/02/2001 |
| 6150557 | Compounds Novel 1, 4, 5-substituted imidazole compounds and compositions for use in therapy as cytokine inhibitors.... | 11/21/2000 |
| 6143789 | Naphthalene compounds Compound of formula (I): ##STR1## wherein: T represents alkylene, A and B together form a naphthalene, dihydronaphthalene, or tetrahydronaphthalene group, R represents hydrogen, hydroxy, R' or OR', R' being as defined in the description, G1 | 11/07/2000 |
| 6140372 | Acyl derivatives of melatonin and of melatoninergic analogues and their use as medicinal products The invention relates to derivatives of general formula I ##STR1## as defined in the description. The invention also relates to a process for their preparation and to their therapeutic use, in particular for the treatment of complaints associated wit... | 10/31/2000 |
